Logo image of ABI.BR

ANHEUSER-BUSCH INBEV SA/NV (ABI.BR) Stock Fundamental Analysis

EBR:ABI - Euronext Brussels - BE0974293251 - Common Stock - Currency: EUR

57.76  +0.06 (+0.1%)

Fundamental Rating

4

Taking everything into account, ABI scores 4 out of 10 in our fundamental rating. ABI was compared to 23 industry peers in the Beverages industry. ABI has a medium profitability rating, but doesn't score so well on its financial health evaluation. ABI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ABI had positive earnings in the past year.
ABI had a positive operating cash flow in the past year.
In the past 5 years ABI has always been profitable.
ABI had a positive operating cash flow in each of the past 5 years.
ABI.BR Yearly Net Income VS EBIT VS OCF VS FCFABI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

ABI's Return On Assets of 2.83% is in line compared to the rest of the industry. ABI outperforms 47.83% of its industry peers.
Looking at the Return On Equity, with a value of 7.48%, ABI is in line with its industry, outperforming 56.52% of the companies in the same industry.
ABI's Return On Invested Capital of 6.49% is on the low side compared to the rest of the industry. ABI is outperformed by 60.87% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ABI is in line with the industry average of 7.90%.
The 3 year average ROIC (6.05%) for ABI is below the current ROIC(6.49%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.83%
ROE 7.48%
ROIC 6.49%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ABI.BR Yearly ROA, ROE, ROICABI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ABI's Profit Margin of 9.80% is in line compared to the rest of the industry. ABI outperforms 52.17% of its industry peers.
ABI's Profit Margin has declined in the last couple of years.
The Operating Margin of ABI (25.87%) is better than 78.26% of its industry peers.
In the last couple of years the Operating Margin of ABI has declined.
ABI has a Gross Margin of 55.25%. This is in the better half of the industry: ABI outperforms 60.87% of its industry peers.
ABI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 25.87%
PM (TTM) 9.8%
GM 55.25%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
ABI.BR Yearly Profit, Operating, Gross MarginsABI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

ABI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ABI has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ABI has been increased compared to 5 years ago.
The debt/assets ratio for ABI has been reduced compared to a year ago.
ABI.BR Yearly Shares OutstandingABI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
ABI.BR Yearly Total Debt VS Total AssetsABI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

Based on the Altman-Z score of 1.78, we must say that ABI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ABI (1.78) is worse than 69.57% of its industry peers.
The Debt to FCF ratio of ABI is 6.45, which is on the high side as it means it would take ABI, 6.45 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.45, ABI is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
ABI has a Debt/Equity ratio of 0.90. This is a neutral value indicating ABI is somewhat dependend on debt financing.
ABI has a Debt to Equity ratio (0.90) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.45
Altman-Z 1.78
ROIC/WACC1.07
WACC6.07%
ABI.BR Yearly LT Debt VS Equity VS FCFABI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 0.70 indicates that ABI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.70, ABI is doing worse than 91.30% of the companies in the same industry.
A Quick Ratio of 0.54 indicates that ABI may have some problems paying its short term obligations.
ABI has a worse Quick ratio (0.54) than 65.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.54
ABI.BR Yearly Current Assets VS Current LiabilitesABI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.33% over the past year.
The Earnings Per Share has been decreasing by -1.83% on average over the past years.
ABI shows a decrease in Revenue. In the last year, the revenue decreased by -1.45%.
The Revenue has been growing slightly by 2.69% on average over the past years.
EPS 1Y (TTM)13.33%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%8%
Revenue 1Y (TTM)-1.45%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%-6.32%

3.2 Future

ABI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.42% yearly.
Based on estimates for the next years, ABI will show a small growth in Revenue. The Revenue will grow by 4.35% on average per year.
EPS Next Y4.12%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
EPS Next 5Y11.42%
Revenue Next Year1.78%
Revenue Next 2Y3.14%
Revenue Next 3Y3.48%
Revenue Next 5Y4.35%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABI.BR Yearly Revenue VS EstimatesABI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B
ABI.BR Yearly EPS VS EstimatesABI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.88 indicates a rather expensive valuation of ABI.
ABI's Price/Earnings ratio is a bit cheaper when compared to the industry. ABI is cheaper than 60.87% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.18, ABI is valued a bit cheaper.
A Price/Forward Earnings ratio of 16.32 indicates a correct valuation of ABI.
60.87% of the companies in the same industry are cheaper than ABI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.34, ABI is valued rather cheaply.
Industry RankSector Rank
PE 18.88
Fwd PE 16.32
ABI.BR Price Earnings VS Forward Price EarningsABI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABI is valued a bit cheaper than 65.22% of the companies in the same industry.
ABI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ABI is cheaper than 73.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.67
EV/EBITDA 8.86
ABI.BR Per share dataABI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ABI's earnings are expected to grow with 12.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.58
PEG (5Y)N/A
EPS Next 2Y8.45%
EPS Next 3Y12.23%

2

5. Dividend

5.1 Amount

ABI has a Yearly Dividend Yield of 1.21%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.94, ABI is paying slightly less dividend.
With a Dividend Yield of 1.21, ABI pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

The dividend of ABI decreases each year by -12.03%.
Dividend Growth(5Y)-12.03%
Div Incr Years3
Div Non Decr Years4
ABI.BR Yearly Dividends per shareABI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

45.64% of the earnings are spent on dividend by ABI. This is a bit on the high side, but may be sustainable.
DP45.64%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
ABI.BR Yearly Income VS Free CF VS DividendABI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
ABI.BR Dividend Payout.ABI.BR Dividend Payout, showing the Payout Ratio.ABI.BR Dividend Payout.PayoutRetained Earnings

ANHEUSER-BUSCH INBEV SA/NV

EBR:ABI (7/16/2025, 2:27:01 PM)

57.76

+0.06 (+0.1%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners19.76%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap111.95B
Analysts83.75
Price Target72.98 (26.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend1.16
Dividend Growth(5Y)-12.03%
DP45.64%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.01%
Min EPS beat(2)5.76%
Max EPS beat(2)20.27%
EPS beat(4)4
Avg EPS beat(4)10.29%
Min EPS beat(4)4.3%
Max EPS beat(4)20.27%
EPS beat(8)8
Avg EPS beat(8)6.77%
EPS beat(12)10
Avg EPS beat(12)7.21%
EPS beat(16)13
Avg EPS beat(16)7.45%
Revenue beat(2)1
Avg Revenue beat(2)0.19%
Min Revenue beat(2)-4.2%
Max Revenue beat(2)4.57%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)4.57%
Revenue beat(8)2
Avg Revenue beat(8)-1.53%
Revenue beat(12)4
Avg Revenue beat(12)-1.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.4%
PT rev (1m)-0.53%
PT rev (3m)1.17%
EPS NQ rev (1m)0.61%
EPS NQ rev (3m)-1.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.52%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 18.88
Fwd PE 16.32
P/S 2.18
P/FCF 11.67
P/OCF 8.67
P/B 1.67
P/tB N/A
EV/EBITDA 8.86
EPS(TTM)3.06
EY5.3%
EPS(NY)3.54
Fwd EY6.13%
FCF(TTM)4.95
FCFY8.57%
OCF(TTM)6.66
OCFY11.53%
SpS26.44
BVpS34.6
TBVpS-31.97
PEG (NY)4.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 7.48%
ROCE 8.91%
ROIC 6.49%
ROICexc 6.95%
ROICexgc 96.58%
OM 25.87%
PM (TTM) 9.8%
GM 55.25%
FCFM 18.73%
ROA(3y)2.69%
ROA(5y)2.17%
ROE(3y)7.38%
ROE(5y)6.2%
ROIC(3y)6.05%
ROIC(5y)5.66%
ROICexc(3y)6.43%
ROICexc(5y)6.06%
ROICexgc(3y)81%
ROICexgc(5y)72.75%
ROCE(3y)8.3%
ROCE(5y)7.79%
ROICexcg growth 3Y11.31%
ROICexcg growth 5Y15.72%
ROICexc growth 3Y4.65%
ROICexc growth 5Y2.73%
OM growth 3Y-0.42%
OM growth 5Y-3.7%
PM growth 3Y4.44%
PM growth 5Y-10.98%
GM growth 3Y-1.3%
GM growth 5Y-1.99%
F-Score8
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.45
Debt/EBITDA 3.37
Cap/Depr 69.68%
Cap/Sales 6.46%
Interest Coverage 4.24
Cash Conversion 71.67%
Profit Quality 191.15%
Current Ratio 0.7
Quick Ratio 0.54
Altman-Z 1.78
F-Score8
WACC6.07%
ROIC/WACC1.07
Cap/Depr(3y)85.67%
Cap/Depr(5y)89.39%
Cap/Sales(3y)7.73%
Cap/Sales(5y)8.33%
Profit Quality(3y)163.01%
Profit Quality(5y)238.24%
High Growth Momentum
Growth
EPS 1Y (TTM)13.33%
EPS 3Y4.79%
EPS 5Y-1.83%
EPS Q2Q%8%
EPS Next Y4.12%
EPS Next 2Y8.45%
EPS Next 3Y12.23%
EPS Next 5Y11.42%
Revenue 1Y (TTM)-1.45%
Revenue growth 3Y3.25%
Revenue growth 5Y2.69%
Sales Q2Q%-6.32%
Revenue Next Year1.78%
Revenue Next 2Y3.14%
Revenue Next 3Y3.48%
Revenue Next 5Y4.35%
EBIT growth 1Y5.98%
EBIT growth 3Y2.81%
EBIT growth 5Y-1.1%
EBIT Next Year40.75%
EBIT Next 3Y16.41%
EBIT Next 5Y12.43%
FCF growth 1Y29.73%
FCF growth 3Y6.91%
FCF growth 5Y4.78%
OCF growth 1Y13.49%
OCF growth 3Y0.57%
OCF growth 5Y1.41%